Short Interest in Innovation Pharmaceuticals Inc. (OTCMKTS:IPIX) Grows By 9.6%

Innovation Pharmaceuticals Inc. (OTCMKTS:IPIXGet Free Report) was the target of a significant increase in short interest in the month of August. As of August 31st, there was short interest totalling 511,100 shares, an increase of 9.6% from the August 15th total of 466,200 shares. Based on an average daily trading volume, of 948,300 shares, the short-interest ratio is presently 0.5 days.

Innovation Pharmaceuticals Stock Down 10.3 %

IPIX traded down $0.00 during trading on Tuesday, hitting $0.02. 78,738 shares of the stock traded hands, compared to its average volume of 375,206. The business has a 50 day moving average price of $0.02 and a 200 day moving average price of $0.02. Innovation Pharmaceuticals has a twelve month low of $0.01 and a twelve month high of $0.04.

Innovation Pharmaceuticals Company Profile

(Get Free Report)

Innovation Pharmaceuticals Inc, a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. The company's lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19.

Recommended Stories

Receive News & Ratings for Innovation Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovation Pharmaceuticals and related companies with's FREE daily email newsletter.